0.55(1.24%) Volume: 162,515 8:08PM EDT| Market Cap : 1.71 B | Enterprise Value : 1.88 B | P/E (TTM) : 84.42 | P/B : 3.21 |
|---|
OMCL has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
OMCL has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
GuruFocus Financial Strength Rank measures how strong a companys financial situation is. It is based on these factors
1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.
A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.
| vs
industry |
vs
history |
||
|---|---|---|---|
| Cash-to-Debt | 0.15 |
OMCL's Cash-to-Debt is ranked lower than
92% of the 2082 Companies in the Global Health Information Services industry. ( Industry Median: 8.37 vs. OMCL: 0.15 ) Ranked among companies with meaningful Cash-to-Debt only. |
OMCL'
s Cash-to-Debt Range Over the Past 10 Years
Min: 0.15 Med: No Debt Max: No Debt Current: 0.15 |
| Equity-to-Asset | 0.53 |
OMCL's Equity-to-Asset is ranked lower than
59% of the 1985 Companies in the Global Health Information Services industry. ( Industry Median: 0.60 vs. OMCL: 0.53 ) Ranked among companies with meaningful Equity-to-Asset only. |
OMCL'
s Equity-to-Asset Range Over the Past 10 Years
Min: -0.57 Med: 0.64 Max: 0.78 Current: 0.53 |
| Debt-to-Equity | 0.41 |
OMCL's Debt-to-Equity is ranked lower than
62% of the 1133 Companies in the Global Health Information Services industry. ( Industry Median: 0.27 vs. OMCL: 0.41 ) Ranked among companies with meaningful Debt-to-Equity only. |
OMCL'
s Debt-to-Equity Range Over the Past 10 Years
Min: -0.34 Med: 0.04 Max: 0.59 Current: 0.41 |
| Debt-to-EBITDA | 3.67 |
OMCL's Debt-to-EBITDA is ranked lower than
78% of the 1031 Companies in the Global Health Information Services industry. ( Industry Median: 1.33 vs. OMCL: 3.67 ) Ranked among companies with meaningful Debt-to-EBITDA only. |
OMCL'
s Debt-to-EBITDA Range Over the Past 10 Years
Min: 3.67 Med: 3.79 Max: 3.92 Current: 3.67 |
| Interest Coverage | 0.84 |
OMCL's Interest Coverage is ranked lower than
97% of the 1570 Companies in the Global Health Information Services industry. ( Industry Median: 140.00 vs. OMCL: 0.84 ) Ranked among companies with meaningful Interest Coverage only. |
OMCL'
s Interest Coverage Range Over the Past 10 Years
Min: 0.77 Med: 196.96 Max: 2680.5 Current: 0.84 |
| Piotroski F-Score: 5 |
|
| Altman Z-Score: 3.35 |
|
| Beneish M-Score: -2.25 |
|
| WACC vs ROIC |
1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank
| vs
industry |
vs
history |
||
|---|---|---|---|
| Operating Margin % | 0.80 |
OMCL's Operating Margin % is ranked lower than
63% of the 2027 Companies in the Global Health Information Services industry. ( Industry Median: 4.54 vs. OMCL: 0.80 ) Ranked among companies with meaningful Operating Margin % only. |
OMCL'
s Operating Margin % Range Over the Past 10 Years
Min: 0.8 Med: 6.75 Max: 11.25 Current: 0.8 |
| Net Margin % | 2.88 |
OMCL's Net Margin % is ranked lower than
52% of the 2027 Companies in the Global Health Information Services industry. ( Industry Median: 3.36 vs. OMCL: 2.88 ) Ranked among companies with meaningful Net Margin % only. |
OMCL'
s Net Margin % Range Over the Past 10 Years
Min: 0.09 Med: 4.64 Max: 6.92 Current: 2.88 |
| ROE % | 4.46 |
OMCL's ROE % is ranked lower than
55% of the 1969 Companies in the Global Health Information Services industry. ( Industry Median: 6.14 vs. OMCL: 4.46 ) Ranked among companies with meaningful ROE % only. |
OMCL'
s ROE % Range Over the Past 10 Years
Min: 0.14 Med: 4.78 Max: 8.26 Current: 4.46 |
| ROA % | 2.21 |
OMCL's ROA % is ranked lower than
53% of the 2097 Companies in the Global Health Information Services industry. ( Industry Median: 3.01 vs. OMCL: 2.21 ) Ranked among companies with meaningful ROA % only. |
OMCL'
s ROA % Range Over the Past 10 Years
Min: 0.08 Med: 3.47 Max: 5.8 Current: 2.21 |
| ROC (Joel Greenblatt) % | 4.26 |
OMCL's ROC (Joel Greenblatt) % is ranked lower than
62% of the 2065 Companies in the Global Health Information Services industry. ( Industry Median: 20.86 vs. OMCL: 4.26 ) Ranked among companies with meaningful ROC (Joel Greenblatt) % only. |
OMCL'
s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 2.43 Med: 41.98 Max: 64.63 Current: 4.26 |
| 3-Year Revenue Growth Rate | 15.40 |
OMCL's 3-Year Revenue Growth Rate is ranked higher than
75% of the 1648 Companies in the Global Health Information Services industry. ( Industry Median: 5.80 vs. OMCL: 15.40 ) Ranked among companies with meaningful 3-Year Revenue Growth Rate only. |
OMCL'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -53.3 Med: 11.3 Max: 20.9 Current: 15.4 |
| 3-Year EBITDA Growth Rate | -8.10 |
OMCL's 3-Year EBITDA Growth Rate is ranked lower than
76% of the 1481 Companies in the Global Health Information Services industry. ( Industry Median: 8.80 vs. OMCL: -8.10 ) Ranked among companies with meaningful 3-Year EBITDA Growth Rate only. |
OMCL'
s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: 0 Med: 5.5 Max: 130.8 Current: -8.1 |
| 3-Year EPS without NRI Growth Rate | -13.90 |
OMCL's 3-Year EPS without NRI Growth Rate is ranked lower than
78% of the 1387 Companies in the Global Health Information Services industry. ( Industry Median: 9.80 vs. OMCL: -13.90 ) Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only. |
OMCL'
s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0 Med: -7.6 Max: 260.9 Current: -13.9 |
| Joel Greenblatt 33,566 sh (New) | Ken Fisher 492,202 sh (-0.02%) Mariko Gordon 1,353,369 sh (-12.00%) |
| Ken Fisher 528,919 sh (+7.46%) | Mariko Gordon 1,216,632 sh (-10.10%) Joel Greenblatt 4,705 sh (-85.98%) |
| Ken Fisher 530,569 sh (+0.31%) | Joel Greenblatt Sold Out Mariko Gordon 970,386 sh (-20.24%) |
(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
| Guru | Date | Trades | Impact to Portfolio | Price Range * (?) | Current Price | Change from Average | Current Shares | |
|---|---|---|---|---|---|---|---|---|
| Ken Fisher | 2018-03-31 | Add 38.62% | 0.01% | $40.1 - $52.45 | $ 43.90 | -5% | 735,464 |  |
| Mariko Gordon | 2017-12-31 | Reduce -20.24% | 0.78% | $45.3 - $54.5 | $ 43.90 | -13% | 970,386 | |
| Ken Fisher | 2017-12-31 | Add 0.31% | $45.3 - $54.5 | $ 43.90 | -13% | 530,569 | | |
| Joel Greenblatt | 2017-12-31 | Sold Out | $45.3 - $54.5 | $ 43.90 | -13% | 0 | | |
| Mariko Gordon | 2017-09-30 | Reduce -10.10% | 0.35% | $42.25 - $52.15 | $ 43.90 | -8% | 1,216,632 | |
| Ken Fisher | 2017-09-30 | Add 7.46% | $42.25 - $52.15 | $ 43.90 | -8% | 528,919 | | |
| Joel Greenblatt | 2017-09-30 | Reduce -85.98% | 0.02% | $42.25 - $52.15 | $ 43.90 | -8% | 4,705 | |
| Mariko Gordon | 2017-06-30 | Reduce -12.00% | 0.44% | $39.55 - $44.4 | $ 43.90 | 6% | 1,353,369 | |
| Ken Fisher | 2017-06-30 | Reduce -0.02% | $39.55 - $44.4 | $ 43.90 | 6% | 492,202 | | |
| Joel Greenblatt | 2017-06-30 | New Buy | 0.02% | $39.55 - $44.4 | $ 43.90 | 6% | 33,566 | |
More recent guru trades are included for Premium Members only!! More recent guru trades are included for USA Subscribe Members only!! What is Peter Lynch Charts )| Industry: | Application Software » Health Information Services NAICS: 621999 SIC: 8099 | |
|---|---|---|
| Compare: | NAS:PINC, NAS:INOV, HKSE:02666, NYSE:EVH, SZSE:300451, NAS:QSII, NAS:TRHC, NAS:HSTM, SZSE:300253, NAS:RCM, TSE:3902, LSE:CRW, LSE:EMIS, NYSE:TDOC, ASX:PME, XPAR:CGM, XTER:COP, SHSE:603990, TSE:4820, TSE:3733 » details | |
| Traded in other countries: | OC9.Germany, | |
| Headquarter Location: | USA |
| vs
industry |
vs
history |
||
|---|---|---|---|
| PE Ratio | 84.42 |
OMCL's PE Ratio is ranked lower than
86% of the 1288 Companies in the Global Health Information Services industry. ( Industry Median: 27.61 vs. OMCL: 84.42 ) Ranked among companies with meaningful PE Ratio only. |
OMCL'
s PE Ratio Range Over the Past 10 Years
Min: 8.9 Med: 41.16 Max: 1930 Current: 84.42 |
| Forward PE Ratio | 22.47 |
OMCL's Forward PE Ratio is ranked higher than
53% of the 318 Companies in the Global Health Information Services industry. ( Industry Median: 24.04 vs. OMCL: 22.47 ) Ranked among companies with meaningful Forward PE Ratio only. |
N/A |
| PE Ratio without NRI | 84.42 |
OMCL's PE Ratio without NRI is ranked lower than
86% of the 1279 Companies in the Global Health Information Services industry. ( Industry Median: 27.94 vs. OMCL: 84.42 ) Ranked among companies with meaningful PE Ratio without NRI only. |
OMCL'
s PE Ratio without NRI Range Over the Past 10 Years
Min: 8.9 Med: 41.16 Max: 1930 Current: 84.42 |
| PB Ratio | 3.21 |
OMCL's PB Ratio is ranked higher than
50% of the 1923 Companies in the Global Health Information Services industry. ( Industry Median: 3.25 vs. OMCL: 3.21 ) Ranked among companies with meaningful PB Ratio only. |
OMCL'
s PB Ratio Range Over the Past 10 Years
Min: 0.96 Med: 2.36 Max: 4.33 Current: 3.21 |
| PS Ratio | 2.44 |
OMCL's PS Ratio is ranked higher than
51% of the 1917 Companies in the Global Health Information Services industry. ( Industry Median: 2.57 vs. OMCL: 2.44 ) Ranked among companies with meaningful PS Ratio only. |
OMCL'
s PS Ratio Range Over the Past 10 Years
Min: 0.94 Med: 2.16 Max: 4.69 Current: 2.44 |
| Price-to-Free-Cash-Flow | 154.02 |
OMCL's Price-to-Free-Cash-Flow is ranked lower than
92% of the 689 Companies in the Global Health Information Services industry. ( Industry Median: 28.70 vs. OMCL: 154.02 ) Ranked among companies with meaningful Price-to-Free-Cash-Flow only. |
OMCL'
s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 8.02 Med: 27.98 Max: 184.04 Current: 154.02 |
| Price-to-Operating-Cash-Flow | 65.25 |
OMCL's Price-to-Operating-Cash-Flow is ranked lower than
87% of the 889 Companies in the Global Health Information Services industry. ( Industry Median: 20.00 vs. OMCL: 65.25 ) Ranked among companies with meaningful Price-to-Operating-Cash-Flow only. |
OMCL'
s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 6.98 Med: 20.16 Max: 10100 Current: 65.25 |
| EV-to-EBIT | 327.36 |
OMCL's EV-to-EBIT is ranked lower than
98% of the 1329 Companies in the Global Health Information Services industry. ( Industry Median: 20.79 vs. OMCL: 327.36 ) Ranked among companies with meaningful EV-to-EBIT only. |
OMCL'
s EV-to-EBIT Range Over the Past 10 Years
Min: -224.8 Med: 23.4 Max: 423.3 Current: 327.36 |
| EV-to-EBITDA | 32.91 |
OMCL's EV-to-EBITDA is ranked lower than
74% of the 1441 Companies in the Global Health Information Services industry. ( Industry Median: 16.23 vs. OMCL: 32.91 ) Ranked among companies with meaningful EV-to-EBITDA only. |
OMCL'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 3.7 Med: 15.7 Max: 53 Current: 32.91 |
| EV-to-Revenue | 2.65 |
OMCL's EV-to-Revenue is ranked lower than
51% of the 2002 Companies in the Global Health Information Services industry. ( Industry Median: 2.59 vs. OMCL: 2.65 ) Ranked among companies with meaningful EV-to-Revenue only. |
OMCL'
s EV-to-Revenue Range Over the Past 10 Years
Min: 0.4 Med: 1.9 Max: 4.3 Current: 2.65 |
| PEG Ratio | 18.15 |
OMCL's PEG Ratio is ranked lower than
92% of the 603 Companies in the Global Health Information Services industry. ( Industry Median: 2.18 vs. OMCL: 18.15 ) Ranked among companies with meaningful PEG Ratio only. |
OMCL'
s PEG Ratio Range Over the Past 10 Years
Min: 0.5 Med: 2.17 Max: 344.97 Current: 18.15 |
| Shiller PE Ratio | 98.82 |
OMCL's Shiller PE Ratio is ranked lower than
83% of the 359 Companies in the Global Health Information Services industry. ( Industry Median: 39.15 vs. OMCL: 98.82 ) Ranked among companies with meaningful Shiller PE Ratio only. |
OMCL'
s Shiller PE Ratio Range Over the Past 10 Years
Min: 36.8 Med: 58.62 Max: 124.53 Current: 98.82 |
| Current Ratio | 1.73 |
OMCL's Current Ratio is ranked lower than
56% of the 1912 Companies in the Global Health Information Services industry. ( Industry Median: 1.96 vs. OMCL: 1.73 ) Ranked among companies with meaningful Current Ratio only. |
OMCL'
s Current Ratio Range Over the Past 10 Years
Min: 0.73 Med: 2.29 Max: 4.68 Current: 1.73 |
| Quick Ratio | 1.28 |
OMCL's Quick Ratio is ranked lower than
68% of the 1912 Companies in the Global Health Information Services industry. ( Industry Median: 1.81 vs. OMCL: 1.28 ) Ranked among companies with meaningful Quick Ratio only. |
OMCL'
s Quick Ratio Range Over the Past 10 Years
Min: 0.52 Med: 1.93 Max: 4.38 Current: 1.28 |
| Days Inventory | 76.95 |
OMCL's Days Inventory is ranked lower than
81% of the 1183 Companies in the Global Health Information Services industry. ( Industry Median: 17.94 vs. OMCL: 76.95 ) Ranked among companies with meaningful Days Inventory only. |
OMCL'
s Days Inventory Range Over the Past 10 Years
Min: 35.45 Med: 55.69 Max: 76.95 Current: 76.95 |
| Days Sales Outstanding | 96.44 |
OMCL's Days Sales Outstanding is ranked lower than
70% of the 1642 Companies in the Global Health Information Services industry. ( Industry Median: 68.90 vs. OMCL: 96.44 ) Ranked among companies with meaningful Days Sales Outstanding only. |
OMCL'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 56.2 Med: 69.97 Max: 96.44 Current: 96.44 |
| Days Payable | 44.73 |
OMCL's Days Payable is ranked higher than
50% of the 1444 Companies in the Global Health Information Services industry. ( Industry Median: 45.06 vs. OMCL: 44.73 ) Ranked among companies with meaningful Days Payable only. |
OMCL'
s Days Payable Range Over the Past 10 Years
Min: 26.08 Med: 35.76 Max: 50.91 Current: 44.73 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -1.90 |
OMCL's 3-Year Average Share Buyback Ratio is ranked higher than
58% of the 1376 Companies in the Global Health Information Services industry. ( Industry Median: -3.20 vs. OMCL: -1.90 ) Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only. |
OMCL'
s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -140.8 Med: -2.6 Max: 1.6 Current: -1.9 |
| vs
industry |
vs
history |
||
|---|---|---|---|
| Price-to-Intrinsic-Value-Projected-FCF | 2.17 | ||
| Price-to-Intrinsic-Value-DCF (Earnings Based) | 7.90 |
OMCL's Price-to-Intrinsic-Value-DCF (Earnings Based) is ranked lower than
99.99% of the 129 Companies in the Global Health Information Services industry. ( Industry Median: 1.82 vs. OMCL: 7.90 ) Ranked among companies with meaningful Price-to-Intrinsic-Value-DCF (Earnings Based) only. |
OMCL'
s Price-to-Intrinsic-Value-DCF (Earnings Based) Range Over the Past 10 Years
Min: 3.46 Med: 3.73 Max: 161.43 Current: 7.9 |
| Price-to-Median-PS-Value | 1.12 |
OMCL's Price-to-Median-PS-Value is ranked higher than
51% of the 1595 Companies in the Global Health Information Services industry. ( Industry Median: 1.14 vs. OMCL: 1.12 ) Ranked among companies with meaningful Price-to-Median-PS-Value only. |
OMCL'
s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.25 Med: 1.09 Max: 1.98 Current: 1.12 |
| Earnings Yield (Greenblatt) % | 0.30 |
OMCL's Earnings Yield (Greenblatt) % is ranked lower than
62% of the 2098 Companies in the Global Health Information Services industry. ( Industry Median: 1.99 vs. OMCL: 0.30 ) Ranked among companies with meaningful Earnings Yield (Greenblatt) % only. |
OMCL'
s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -0.8 Med: 3.9 Max: 19 Current: 0.3 |
| Forward Rate of Return (Yacktman) % | 1.53 |
OMCL's Forward Rate of Return (Yacktman) % is ranked lower than
73% of the 834 Companies in the Global Health Information Services industry. ( Industry Median: 10.67 vs. OMCL: 1.53 ) Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only. |
OMCL'
s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 0.5 Med: 21.9 Max: 25.3 Current: 1.53 |
| Revenue (TTM) (Mil) $ | 716.17 |
|---|---|
| EPS (TTM) $ | 0.52 |
| Beta | 0.70 |
| Volatility | 23.93% |
| 52-Week Range $ | 38.00 - 55.40 |
| Shares Outstanding (Mil) | 38.78 |
| Dec18 | Dec19 | Dec20 | |
|---|---|---|---|
| Revenue (Mil $) | 790 | 872 | 959 |
| EBIT (Mil $) | |||
| EBITDA (Mil $) | |||
| EPS ($) | 1.97 | 2.44 | 3.25 |
| EPS without NRI ($) | 1.97 | 2.44 | 3.25 |
| EPS Growth Rate (Future 3Y To 5Y Estimate) | 2.00% | ||
| Dividends per Share ($) | |||
|
GF Chat
Excel Add-In GURUF
API
My Portfolios
Create New Portfolio
Portfolio Contest
My Gurus
Personalize
My Gurus
Email Alerts
Stock PDF
RSS
Website
Filings
Manual of Stocks™ Web APP